Summary. Oxytocin (10 mi.u./\g=m\1/h) or vehicle (0\m=.\5% chlorobutanol in saline, 1 \g=m\1/h) was chronically infused directly into the corpus luteum of normally cyclic rhesus monkeys, by means of an Alzet pump\p=n-\ovarian cannula system. Infusion of oxytocin (N = 6) or vehicle (N = 5) began 6 days after the preovulatory oestradiol surge, and daily peripheral blood samples were taken. Oxytocin caused a significant (P < 0\m=.\05) decrease in progesterone, beginning 1 day after treatment, and oestradiol after 4 days; progesterone and oestradiol remained significantly depressed until menstruation. However, peripheral LH concentrations remained unchanged. The duration of the luteal phase, menstrual cycle and the onset of menses from the initiation of oxytocin infusion were significantly (P < 0\m=.\01) shorter when compared to those of vehicle\x=req-\ treated controls. These results show that oxytocin can induce functional luteolysis in the primate and supports the hypothesis that oxytocin of luteal origin may play a role in spontaneous luteolysis.
Introduction
Exogenously administered oxytocin has been shown to induce premature luteal regression in several domestic animals (Armstrong & Hansel, 1959; Milne, 1963; Black & Duby, 1965; Auletta, Currie & Black, 1972a; Cooke & Knifton, 1981) . The neurohypophysial hormones, oxytocin and vasopressin, have been isolated from the human corpus luteum . Oxytocin has also been identified in the bovine (Fields, Eldridge, Fuchs, Roberts & Fields, 1983) , ovine and monkey (Khan-Dawood, Marut & Dawood, 1984) corpus luteum, and in human ovarian stroma and preovulatory follicles (Khan-Dawood & Dawood, 1983) . A potential role for endogenous ovarian oxytocin in regulating luteal function is supported by several new observations of sheep: (1) luteolysis is delayed in sheep immunized against oxytocin (Sheldrick, Mitchell & Flint, 1980) ; (2) peripheral blood concentrations of oxytocin (Sheldrick & Flint, 1981) and neurophysins (Fairclough et al, 1980) parallel progesterone values throughout the life-span of the corpus luteum, and (3) oxytocin is selectively released into the ovarian venous effluent ipsilateral to the corpus luteum after systemic administration of a potent prostaglandin (PG) F-2a analogue, cloprostenol (Flint & Sheldrick, 1982) . Collectively, these studies suggest that oxytocin modulates the luteolytic action of PGF-2a in sheep. In primates, however, measurement of oxytocin in the peripheral circulation has not revealed any significant changes associated with luteal regression (Falconer, Mitchell, Mountford & Robinson, 1980; Mitchell, Haynes, Anderson & Turnbull, 1981) . Nevertheless, Tan, Tweedale & Biggs (1982) reported that high concentrations of oxytocin (400-800 mi.u./ml) caused inhibition of basal and hCG-stimulated "progesterone production by dispersed human luteal cells in vitro. We have now studied the effects of continuous infusion of oxytocin directly into the corpus luteum of rhesus monkeys.
Materials and Methods
Rhesus monkeys (Macaca mulatta), purchased from National Institutes of Health and exhibiting at least one normal, ovulatory menstrual cycle, were used. Daily vaginal lavage (to determine the onset and duration of menstrual bleeding) and serial peripheral blood progesterone, oestradiol and LH concentrations, were used to document cyclic activity. In the luteal phase, a progesterone value > 2 ng/ml was considered indicative of an ovulatory cycle (Auletta, Caldwell, van Wagenen & Morris, 1972b) . During the treatment cycle, blood was taken by femoral or saphenous vein puncture on Days 10-18 from the onset of menses, to determine the day of the preovulatory oestradiol surge. Consequently, a daily blood sample was withdrawn for the measurement of progesterone and oestradiol by radioimmunoassays (Auletta, Agins & Scommegna, 1978) and LH by the rat interstitial cell testosterone assay (Auletta, Kamps, Pories, Bisset & Gibson, 1984) . A sensitivity of 1 -5 ng of LH (LER 1909-2) per tube when assaying 20-50 pi of plasma in the RICT was achieved; the intra-assay and interassay coefficients of variation were 6-3% and 10-4% respectively (Auletta et al, 1984a) . The sensitivity of the progesterone RIA was 50 pg/tube when assaying 200 pi plasma; the intra-assay and interassay coefficients of variation were 4-6% and 7-2% respectively (Auletta, Agins & Scommegna, 1978) . The sensitivity of the oestradiol RIA was 6 pg/tube when assaying 100 pi of plasma, and the intra-and interassay variations were 7-4% and 11-3% respectively (Auletta, Agins & Scommegna, 1978) .
At 6 days after the preovulatory oestradiol surge, a laparotomy was performed under sterile conditions using pentobarbitone sodium anaesthesia (20 mg/kg body weight), and the ovary bearing the corpus luteum was identified and a cannula introduced. The technique for the insertion of the Alzet pump-cannula system into the corpus luteum has been published elsewhere (Auletta et al, 1984) . The following is a brief description of our technique. The ovarian capsule was punctured with an 18-gauge needle, and a polyvinyl no. 2 cannula, connected to an Alzet osmotic mini-pump (Model 2001 ; Alza Corporation, Palo Alto, CA, U.S.A.), was inserted through the subjacent stroma directly into the corpus luteum (~5 mm). The cannula was secured to the ovary with one 5-0 absorbable suture and one drop of 9-10 adhesive (Eastman Kodak, Rochester, NY, U.S.A.) on the suture knot. Before closure, a separate stab incision in the flank allowed exteriorization of the pump, which was secured subcutaneously, making the pump easily accessible for changing. The cannula and Alzet pump were pre-filled with oxytocin (Sigma Chemical Company, St Louis, MO, U.S.A.) (Grade X, 500 i.u./mg) or vehicle (0-5% chlorobutanol in 0-9% (w/v) NaCl). The model 2001 pump delivers 1 pi solute/h for 7 days (Theeuwes & Yum, 1970) . Oxytocin (10 mi.u./pl/h) or vehicle (1 pl/h) was continuously infused into the corpus luteum until menstruation occurred. The infusion rate of oxytocin (10 mi.u./pl/h) was chosen to approximate physiological rather than pharmacological concentration and is based on our current knowledge of the oxytocin content in human Khan-Dawood & Dawood, 1983) and monkey (Khan-Dawood et al, 1984) luteal tissue. It was 40-80-fold lower than the dose used during in-vitro investigations (Tan et al, 1982) . However, the actual content of oxytocin in the corpus luteum has not been determined, and therefore the possibility remains that the dose is above the physiological production rate. A second laparotomy was performed 1-5 days after the onset of menstruation during the treatment cycle, and the attachment of the cannula to the ovary was verified before removal.
Hormone concentration data were normalized to the day of the preovulatory oestradiol surge and were statistically assessed using one-way analysis of variance with repeated measurements (Steel & Torrie, 1960 ). Significant differences in the intervals of the menstrual cycle were determined by Student's t test.
Results
Intraluteal infusion of oxytocin caused premature, functional luteolysis in 5 of 6 monkeys. As shown in Table 1 , the length of the menstrual cycle, luteal phase, and the time from the initiation of (Fields etal, 1983) , ovine , human (Wathes etal, 1982; Khan-Dawood & Dawood, 1983) and monkey (Khan-Dawood et al, 1984) luteal tissue, and oxytocin inhibits progesterone synthesis by human luteal cells in vitro (Tan et al, 1982) , we suggest that oxytocin may play a role in the primate luteolytic process. Alternatively, oxytocin may be non-specifically toxic or unphysiologically disruptive.
We believe, however, that our results do demonstrate a physiological phenomenon because there is a strong precedent for oxytocin as a luteolytic agent in mammals (Armstrong & Hansel, 1959 ; Milne, 1963 ; Black & Duby, 1965 ; Auletta et al, 1972a ; Cooke & Knifton, 1981 ). Oxytocin is released selectively into the ovarian venous effluent on the corpus luteum side in sheep after systemic administration of a potent PGF-2oc analogue (Flint & Sheldrick, 1982) , PGF-2a is probably the uterine luteolysin in sub-primate mammals (Horton & Poyser, 1976 Khan-Dawood & Dawood, 1983) and monkeys (Khan-Dawood et al, 1984) . Luteolysis was also induced in 2 monkeys (not shown) with an intraluteal infusion rate of 100 mi.u./h; a dose lower than 10 mi.u./h has not been evaluated.
These data convincingly illustrate that oxytocin may mediate luteal demise in the primate. The mechanism of action and the source of this biochemical signal are unknown. suggest that, in sheep, luteal oxytocin may contribute to luteolysis via a systemic action involving the appearance of oxytocin in the ovarian vein caused by . However, hysterectomy does not alter ovarian periodicity in primates (Neill, Johansson & Knobil, 1969; Castracane, Moore & Shaikh, 1979) , and so the ovary bearing the corpus luteum or the corpus luteum itself must be considered. Peripheral infusions of oxytocin at the same dose rate (10 mi.u./h) have not been done, but Wilks (1983) has reported that pharmacological intramuscular injections of oxytocin (2250 i.u.) on Day 6 of the normal primate luteal phase did not alter corpus luteum function, suggesting a local rather than systemic effect of oxytocin. Auletta et al (1984) (Amico, Seif & Robinson, 1981) , stimulate PGF-2a release from the corpus luteum-bearing ovary in the monkey (Auletta et al, 1978) , and induce oxytocin receptors in the endometrium (Roberts, McCracken, Gavagan & Soloff, 1976; McCracken, 1980) . These observations suggest that oestrogens may be the biochemical signal responsible for the synthesis and release of PGF-2a and oxytocin.
